PT-141
Restore Desire & Performance Naturally
A melanocortin receptor agonist that enhances libido and sexual function in both men and women through central nervous system activation.
Prescription Required
Can't get PT-141 through your GP? These telemedicine providers specialize in peptide therapy.
Everlywell
FDA-approved tesamorelin and comprehensive peptide therapy with at-home testing.
Hone Health
Hormone optimization & peptide therapy for men. At-home testing with physician oversight.
Marek Health
Comprehensive hormone and peptide protocols with detailed blood work analysis.
Everlife.md
Peptide-focused telemedicine platform with personalized protocols and ongoing monitoring.
Peter MD
Telemedicine platform specializing in peptide therapy and hormone optimization.
Defy Medical
Established telemedicine clinic offering peptides, HRT, and regenerative therapies.
Always consult with a licensed physician before starting any peptide therapy.
About PT-141
PT-141 (Bremelanotide) is a synthetic peptide originally developed from Melanotan II. Unlike traditional sexual dysfunction treatments that work on the vascular system, PT-141 works directly on the nervous system to enhance sexual desire and arousal. It's FDA-approved for treating hypoactive sexual desire disorder (HSDD) in premenopausal women and is used off-label for male sexual dysfunction. PT-141 is unique because it addresses desire, not just physical function—making it effective for both psychological and physiological aspects of sexual health.
Mechanism of Action
PT-141 activates melanocortin receptors (MC3R and MC4R) in the hypothalamus, the brain region that controls sexual arousal. This central mechanism means it works on desire and arousal at their source, rather than simply increasing blood flow. The result is genuine sexual interest and improved response, not just mechanical function.
How PT-141 Works in Your Body:
- Target Receptors: PT-141 binds to specific receptors that trigger downstream signaling cascades related to its primary benefits.
- Physiological Response: The body responds by modulating natural processes—whether hormone release, tissue repair, or cellular signaling—without replacing endogenous function.
- Timeline: Effects typically begin within a few days, with optimal results seen over the recommended protocol duration.
Dosing Protocol
Frequency
As needed, 45-60 minutes before activity
Timing
Not more than once in 24 hours, max 8 times per month
Duration
Use as needed
Important Notes
1.75mg subcutaneous injection. Effects can last 6-72 hours. Do not use with alcohol.
Clinical Research
3 studies on PT-141
Female HSDD Trial
PT-141 showed statistically significant improvement in sexual desire and reduction in distress.
Journal of Sexual Medicine
Male Erectile Dysfunction
70% of men with ED unresponsive to Viagra showed improvement with PT-141.
Urology
Mechanism Study
Confirmed central nervous system activation via melanocortin pathway, distinct from PDE5 inhibitors.
Annals of the New York Academy of Sciences
PT-141 in Practice
Who PT-141 is for
Premenopausal women with hypoactive sexual desire disorder (HSDD) who want a non-hormonal option, and men with erectile dysfunction unresponsive to PDE5 inhibitors (sildenafil, tadalafil). PT-141 works on desire at the brain level, so it's particularly suited to people whose dysfunction has a psychological or neurological component rather than a purely vascular one.
Who should avoid it
Anyone with uncontrolled hypertension, cardiovascular disease, or a history of stroke. PT-141 transiently raises blood pressure (typically 6 mmHg systolic) and lowers heart rate. It is also not recommended for use with alcohol, which amplifies the nausea and orthostatic effects. Avoid in pregnancy.
Clinical Context
PT-141 (bremelanotide) was FDA-approved as Vyleesi in 2019 for premenopausal HSDD, making it one of the few peptides with a full FDA pathway. The pivotal RECONNECT trials enrolled over 1,200 women across two 24-week studies. About 25% of women on PT-141 reported meaningful improvement in desire vs 17% on placebo. The drug is administered as a single 1.75 mg subcutaneous autoinjector dose at least 45 minutes before anticipated sexual activity, with no more than one dose per 24 hours and a maximum of eight doses per month to limit hyperpigmentation risk from chronic melanocortin activation.
Common Mistakes to Avoid
Using it daily
PT-141 is an as-needed medication, not a daily protocol. Daily dosing risks tachyphylaxis (diminished response) and accelerates hyperpigmentation. Stick to the maximum of 8 doses per month.
Combining with alcohol
Alcohol significantly increases nausea, the most common side effect. Wait at least 2 hours after drinking before dosing — and even then, expect a worse experience.
Expecting an erection drug
PT-141 is not a vasodilator. It enhances desire and arousal centrally. If your issue is purely vascular (failure to maintain), a PDE5 inhibitor is more appropriate. PT-141 shines for libido and central arousal.
Dosing too late
Effects peak 2-6 hours after injection. Most users get the best results dosing 60-90 minutes before activity, not 15 minutes before.
Important Safety Information
Medical Disclaimer: The information provided about PT-141 is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or peptide protocol.
Research Status: While PT-141 has shown promising results in research studies, many peptides are still being studied and may not be approved by regulatory bodies like the FDA for specific uses. The research cited represents ongoing scientific investigation.
Individual Variation: Responses to peptides vary significantly between individuals. What works for one person may not work for another. Side effects, while generally mild, can occur and should be monitored closely.
Quality & Sourcing: If you choose to use peptides, ensure you obtain them from reputable, tested sources. Peptide quality, purity, and proper storage are critical for safety and efficacy.
Legal Considerations: Peptide regulations vary by country and jurisdiction. Some peptides may require a prescription or may have restrictions on their use. Research the laws in your area before obtaining or using peptides.